Fingerprint
Dive into the research topics of 'Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically